Nasdaq:US$15.16 (+0.08) | HKEX:HK$22.56 (-0.74) | AIM:£2.12 (-0.08)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2007-05-23

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China